D&O Insurance in 2025: Navigating the Path to Rating Moderation

D&O Insurance in 2025: Navigating the Path to Rating Moderation The Directors and Officers (D&O) insurance market has been a turbulent arena over recent years, with insurers facing intense pressure from various fronts. Shareholder activism, litigation, and rising loss ratios have all contributed to a fiercely competitive environment. This competition has led to aggressive pricing […]

Catheter Precision, Inc. Completes $3.6 Million Public Offering and Exercises Overallotment Option

Catheter Precision, Inc. Completes $3.6 Million Public Offering and Exercises Overallotment Option In a significant move that underscores its strategic growth plans, Catheter Precision, Inc. recently announced the successful closing of a $3.6 million underwritten public offering. This milestone event, which took place on September 3, 2024, involved the issuance of 805,900 common stock units […]